Citations

Showing 10 of 108083 citations.

Analysis of patient-detected breast cancer recurrence
Kapoor, Trishul , Wrenn, Sean M. , James, Ted A. , CALLAS, PETER W.

Mayo Clinic

Breast Disease | August 25, 2017 | Volume: 37 | Issue: 2 | Pages: 77-82

10.3233/bd-170288 | PMID 28854486 Get It

Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity
McGee‐Lawrence, Meghan E. , Pierce, Jessica L. , Yu, Kanglun , Culpepper, Natasha R., Bradley, Elizabeth W. , Bradley, Elizabeth W , Westendorf, Jennifer J. , McGee-Lawrence, Meghan E

Mayo Clinic

Journal of Cellular Physiology | August 25, 2017 | Volume: 233 | Issue: 4 | Pages: 2671-2680

10.1002/jcp.26148 | PMID 28840938 Get It

Type 2 diabetes is an emerging global health epidemic. Foundations for new therapies are arising from understanding interactions between body systems. Bone‐derived factors that reduce RANKL (receptor activator of NF‐kappa B ligand) signaling in the liver may prevent insulin resistance and the onset of type 2 diabetes. Here we demonstrate that deletion of the epigenetic regulator, Hdac3, in Osx1‐expressing osteoprogenitors prevents insulin resistance induced by high fat diet by increasing serum and skeletal gene expression levels of osteoprotegerin (Opg), a natural inhibitor of RANKL signaling. Removal of one Opg allele in mice lacking Hdac3 in Osx1+ osteoprogenitors increases the insulin resistance of the Hdac3‐deficient mice on a high fat diet. Thus, Hdac3‐depletion in osteoblasts increases expression of Opg, subsequently preserving insulin sensitivity. The Hdac inhibitor vorinostat also increased Opg transcription and histone acetylation of the Opg locus. These results define a new mechanism by which bone regulates systemic insulin sensitivity.
Long‐term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry
Kocarnik, Jonathan , Hua, Xinwei , Hardikar, Sheetal , Lindor, Noralane M. , Win, Aung Ko , Figueiredo, Jane C. , Gallinger, Steven , Cotterchio, Michelle , Adams, Scott V. , Phipps, Amanda I. , Kocarnik, Jonathan M , Figueiredo, Jane C , Newcomb, Polly A. , Win, Aung K , Robinson, Jamaica R.M. , Hopper, John L. , Potter, John D. , Campbell, Peter T. , Cohen, Stacey A.

Mayo Clinic

Cancer | August 25, 2017 | Volume: 123 | Issue: 23 | Pages: 4701-4708

10.1002/cncr.30932 | PMID 28841225 Get It

BACKGROUNDBody weight is associated with colorectal cancer (CRC) risk and survival, but to the authors' knowledge, the impact of long‐term postdiagnostic weight change is unclear. Herein, the authors investigated whether weight change over the 5 years after a diagnosis of CRC is associated with survival.METHODSCRC cases diagnosed from 1997 to 2008 were identified through 4 population‐based cancer registry sites. Participants enrolled within 2 years of diagnosis and reported their height and weight 2 years prior. Follow‐up questionnaires were administered approximately 5 years after diagnosis. Associations between change in weight (in kg) or body mass index (BMI) with overall and CRC‐specific survival were estimated using Cox regression analysis adjusted for age, sex, American Joint Committee on Cancer stage of disease, baseline BMI, nonsteroidal anti‐inflammatory drug use, smoking, time between diagnosis and enrollment, and study site.RESULTSAt the 5‐year postdiagnostic survey, 2049 participants reported higher (53%; median plus 5 kg), unchanged (12%), or lower (35%; median ‐4 kg) weight. Over a median of 5.1 years of subsequent follow‐up (range, 0.3‐9.9 years), 344 participants died (91 of CRC). Long‐term weight loss (per 5 kg) was found to be associated with poorer overall survival (hazard ratio, 1.13; 95% confidence interval, 1.07‐1.21) and CRC‐specific survival (hazard ratio, 1.25; 95% confidence interval, 1.13‐1.39). Significantly lower survival was similarly observed for relative weight loss (>5% vs ≤5% change), BMI reduction (per 1 unit), or BMI category change (overweight to normal vs remaining overweight).CONCLUSIONSWeight loss 5 years after a diagnosis of CRC was found to be significantly associated with decreased long‐term survival, suggesting the importance of avoiding weight loss in survivors of CRC. Future research should attempt to further evaluate this association, accounting for whether this weight change was intentional or represents a marker of declining health. Cancer 2017;123:4701‐4708. © 2017 American Cancer Society.
Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis
Bois, John P. , Crowson, Cynthia S. , Khullar, Tamanna , Achenbach, Sara J., Krause, Megan L., Mankad, Rekha , Mankad, Rekha

Mayo Clinic

Echocardiography | August 25, 2017 | Volume: 34 | Issue: 10 | Pages: 1410-1416

10.1111/echo.13652 | PMID 28840957 Get It

ObjectiveValvular heart disease is common in patients with rheumatoid arthritis (RA). However, there is uncertainty about how often to perform echocardiographic surveillance in this population. The objective of this study was to assess the progression rate of mild and moderate aortic stenosis (AS) in patients with RA.MethodsA population‐based cohort of patients with RA and either mild (2.0–2.9 m/second) or moderate (3.0–3.9 m/second) AS was identified. Demographic, clinical, and echocardiographic data were collected. Annual progression rate of AS was then calculated for the study cohort and the impact of pertinent RA variables on progression rate determined.ResultsSixty‐eight patients with RA and mild or moderate AS met the inclusion requirements. Peak aortic valve (AV) velocity and mean AV gradient increased during the study period, whereas AV area decreased, consistent with progression of AS (P<.001). Mean (SD) annual increase in peak AV jet velocity was 0.05 m/second (0.01) and in mean AV gradient was 1.0 mm Hg (0.18). Mean annual decrease in AV area was 0.04 (0.01) cm2. The progression rate of AS was higher in patients with increased erythrocyte sedimentation rates (ESR) (P=.001).ConclusionsThe rate of AS progression in the RA population was higher in patients with increased ESR but less than that of the reported rate of AS progression in the general population. Although the cause for this finding is uncertain, these results suggest that patients with RA who have mild or moderate AS should undergo echocardiographic surveillance for disease progression similar to that of the general population.
An Elderly Man With a Pacemaker and a Recent Fall
Morales-Lara, Andrea Carolina , Leoni, Juan , Morales-Lara, A Carolina, Leoni, Juan C, Kusumoto, Fred M, Leoni, Juan Carlos , Kusumoto, Fred

Mayo Clinic

JAMA Cardiology | August 25, 2017 | Volume: 2 | Issue: 10 | Pages: 1161

10.1001/jamacardio.2017.1932 | PMID 28832863 Get It

Adding C‐reactive protein and procalcitonin to the model of end‐stage liver disease score improves mortality prediction in patients with complications of cirrhosis
Chirapongsathorn, Sakkarin , Bunraksa, Worawan, Chaiprasert, Amnart, Punpanich, Dollapas, Supasyndh, Ouppatham , Kamath, Patrick S.

Mayo Clinic

Journal of Gastroenterology and Hepatology | August 25, 2017 | Volume: 33 | Issue: 3 | Pages: 726-732

10.1111/jgh.13928 | PMID 28840619 Get It

AbstractBackground and AimThis study aims to determine the performance of models adding C‐reactive protein (CRP) and procalcitonin (PCT) to the model of end‐stage liver disease (MELD) score for mortality prediction in patients hospitalized with complications of cirrhosis.MethodsA prospective cohort study was carried out in consecutive cirrhotic patients admitted with complications of cirrhosis between September 2012 and December 2013 at Phramongkutklao Hospital, Bangkok, Thailand. All patients had venous CRP, PCT, and laboratory values for MELD score calculation measured at emergency room or admission. Cox regression analysis and the c‐statistic were used to predict mortality. The MELD‐CRP score was externally validated in 818 eligible patients from Mayo Clinic, Rochester, using data from 1288 cirrhotic patients diagnosed between 2010 and 2014.ResultsA cohort of 177 patients with cirrhosis was admitted during the study period. Seventy‐one patients were eligible for analysis. The MELD score was predictive of 90‐day mortality odds ratio (OR) 1.19 (95% confidence interval [CI] 1.09–1.32). Adding CRP and/or PCT to the MELD score improved the predictive of 90‐day mortality: MELD‐CRP OR 2.71 (95% CI 1.66–4.99); MELD‐PCT OR 2.72 (95% CI 1.66–4.99); MELD‐CRP‐PCT OR 2.71 (95% CI 1.67–4.92). The c‐statistics for MELD, MELD‐CRP, MELD‐PCT, and MELD‐CRP‐PCT were 0.81, 0.83, 0.84, and 0.85, respectively. Adding CRP and/or PCT to the MELD score also improved 30‐day mortality prediction. Similar results for the MELD‐CRP score were obtained from the Mayo Clinic external validation cohort.ConclusionThe MELD‐CRP, MELD‐PCT, and MELD‐CRP‐PCT scores may be superior to the MELD score alone in predicting mortality in patients hospitalized with complications of cirrhosis.
Report from the Japanese Society of Pediatric Cardiology and Cardiac Surgery Research Committee on Cardio-Vascular Function in Adult Patients with Congenital Heart Disease: Treatment Strategy for Hypoplastic Left Heart Syndrome Based on the Cardiovascular
Kuwata, Seiko, Kurishima, Clara, Kim, JohnHey, Yana, Akiko, Iwamoto, Yoichi, Ishido, Hirotaka , Masutani, Satoshi , Saiki, Hirofumi , Senzaki, Hideaki

Mayo Clinic

Pediatric Cardiology and Cardiac Surgery | August 24, 2017 | Volume: 33 | Issue: 4 | Pages: 269-280

10.9794/jspccs.33.269 Get It

Acute hypoxia in a simulated high-altitude airdrop scenario due to oxygen system failure
Ottestad, William , Hansen, Tor Are S., Pradhan, Gaurav N. , Kåsin, Jan Ivar, Pradhan, Gaurav, Stepánek, Jan , Stepánek, Jan , Høiseth, Lars Øivind , Pradhan, Gaurav N

Mayo Clinic

Journal of Applied Physiology | August 24, 2017 | Volume: 123 | Issue: 6 | Pages: 1443-1450

10.1152/japplphysiol.00169.2017 | PMID 28839003 Get It

High-Altitude High Opening (HAHO) is a military operational procedure in which parachute jumps are performed at high altitude requiring supplemental oxygen, putting personnel at risk of acute hypoxia in the event of oxygen equipment failure. This study was initiated by the Norwegian Army to evaluate potential outcomes during failure of oxygen supply, and to explore physiology during acute severe hypobaric hypoxia. A simulated HAHO without supplemental oxygen was carried out in a hypobaric chamber with decompression to 30,000 ft (9,144 m) and then recompression to ground level with a descent rate of 1,000 ft/min (305 m/min). Nine subjects were studied. Repeated arterial blood gas samples were drawn throughout the entire hypoxic exposure. Additionally, pulse oximetry, cerebral oximetry, and hemodynamic variables were monitored. Desaturation evolved rapidly and the arterial oxygen tensions are among the lowest ever reported in volunteers during acute hypoxia. PaO2 decreased from baseline 18.4 (17.3–19.1) kPa, 138.0 (133.5–143.3) mmHg, to a minimum value of 3.3 (2.9–3.7) kPa, 24.8 (21.6–27.8) mmHg, after 180 (60–210) s, [median (range)], N = 9. Hyperventilation with ensuing hypocapnia was associated with both increased arterial oxygen saturation and cerebral oximetry values, and potentially improved tolerance to severe hypoxia. One subject had a sharp drop in heart rate and cardiac index and lost consciousness 4 min into the hypoxic exposure. A simulated high-altitude airdrop scenario without supplemental oxygen results in extreme hypoxemia and may result in loss of consciousness in some individuals. NEW & NOTEWORTHY This is the first study to investigate physiology and clinical outcome of oxygen system failure in a simulated HAHO scenario. The acquired knowledge is of great value to make valid risk-benefit analyses during HAHO training or operations. The arterial oxygen tensions reported in this hypobaric chamber study are among the lowest ever reported during acute hypoxia.
Sleep Disturbance, Cognitive Decline, and Dementia: A Review
Wu, Mark N. , Rosenberg, Paul B. , Spira, Adam P. , Wennberg, Alexandra , Wennberg, Alexandra M V, Wennberg, Alexandra M V

Mayo Clinic

Seminars in Neurology | August 24, 2017 | Volume: 37 | Issue: 04 | Pages: 395-406

10.1055/s-0037-1604351 | PMID 28837986 Get It

Abstract Approximately half of older people report sleep disturbances, which are associated with various health conditions, including neurodegenerative disease and dementia. Indeed, 60 to 70% of people with cognitive impairment or dementia have sleep disturbances, which are linked to poorer disease prognosis. Sleep disturbances in people with dementia have long been recognized and studied; however, in the past 10 years, researchers have begun to study disturbed sleep, including sleep fragmentation, abnormal sleep duration, and sleep disorders, as risk factors for dementia. In this review the authors summarize evidence linking sleep disturbance and dementia. They describe how specific aspects of sleep (e.g., quality, duration) and the prevalence of clinical sleep disorders (e.g., sleep-disordered breathing, rapid eye movement sleep behavior disorder) change with age; how sleep parameters and sleep disorders are associated with the risk of dementia; how sleep can be disturbed in dementia; and how disturbed sleep affects dementia prognosis. These findings highlight the potential importance of identifying and treating sleep problems and disorders in middle-aged and older adults as a strategy to prevent cognitive decline and dementia. The authors also review recent evidence linking sleep disturbances to the pathophysiology underlying dementing conditions, and briefly summarize available treatments for sleep disorders in people with dementia.
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells
Ruvolo, Peter P. , Ligresti, Giovanni , Ratti, Stefano , Tafuri, Agostino , Steelman, Linda S., Candido, Saverio , Abrams, Stephen Lee , Ruvolo, Vivian R. , Martelli, Alberto Maria , Cocco, Lucio , Libra, Massimo , McCubrey, James Andrew , Ratti, Stefano

Mayo Clinic

Oncotarget | August 24, 2017 | Volume: 8 | Issue: 44 | Pages: 76525-76557

10.18632/oncotarget.20408 | PMID 29100331 Get It